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SUPPLEMENT ARTICLE
A Role for Health Communication in the Continuum of HIV
Care, Treatment, and Prevention
Cecilia Tomori, PhD,* Kathryn Risher, MHS,* Rupali J. Limaye, PhD,† Lynn M. Van Lith, MPA,†
Susannah Gibbs, MSPH,‡ Marina Smelyanskaya, MPH,† and David D. Celentano, MHS, ScD*
Abstract: Health communication has played a pivotal role in HIV
prevention efforts since the beginning of the epidemic. The recent
paradigm of combination prevention, which integrates behavioral,
biomedical, and structural interventions, offers new opportunities for
employing health communication approaches across the entire
continuum of care. We describe key areas where health communi-
cation can signiﬁcantly enhance HIV treatment, care, and prevention,
presenting evidence from interventions that include health commu-
nication components. These interventions rely primarily on interper-
sonal communication, especially individual and group counseling,
both within and beyond clinical settings to enhance the uptake of and
continued engagement in care. Many successful interventions mobi-
lize a network of trained community supporters or accompagnateurs,
who provide education, counseling, psychosocial support, treatment
supervision, and other pragmatic assistance across the care continuum.
Community treatment supporters reduce the burden on overworked
medical providers, engage a wider segment of the community, and
offer a more sustainable model for supporting people living with HIV.
Additionally, mobile technologies are increasingly seen as promising
avenues for ongoing cost-effective communication throughout the
treatment cascade. A broader range of communication approaches,
traditionally employed in HIV prevention efforts, that address com-
munity and sociopolitical levels through mass media, school- or
workplace-based education, and entertainment modalities may be use-
ful to interventions seeking to address the full care continuum. Future
interventions would beneﬁt from development of a framework that
maps appropriate communication theories and approaches onto each
step of the care continuum to evaluate the efﬁcacy of communication
components on treatment outcomes.
Key Words: health communication, continuum of HIV care, behav-
ioral interventions, combination prevention, counseling, mobile
communication technologies
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INTRODUCTION
Public health efforts to reduce the spread of HIV have
undergone a major shift from separate models for prevention
and treatment to the current focus on combination prevention
strategies, which simultaneously address biomedical, behav-
ioral, and social/structural levels.1–4 Particularly with the recent
ﬁnding that antiretroviral therapy (ART) signiﬁcantly reduces
the rate of HIV transmission among HIV discordant couples,5
expanding treatment access and improving adherence have
become essential components of any HIV prevention strategy.
High-quality evidence has been rapidly accumulating for effec-
tive implementation strategies that could be incorporated into
the combination prevention paradigm,4 including evidence
from large trials that take such interventions to the population
level.6 Three randomized controlled trials (RCTs) are underway
to test the efﬁcacy of combination prevention packages.7–10
Numerous investigators have argued for better integra-
tion, within combination prevention, of the contributions of
the social and behavioral sciences to improve access to HIV-
related services and the delivery of services to people living
with HIV across the entire continuum of care2,3,11–13 from
voluntary counseling and testing, through linkage to care,
retention in care, adherence to ART, and, ultimately, viral
suppression.14,15 The aim of this article is to explore the role
of health communication, an approach within the social and
behavioral sciences, across the treatment continuum. The
integration of health communication and other social behav-
ioral interventions as part of combination prevention is par-
ticularly important given the growing emphasis on the early
provision of ART to reduce HIV transmission and the conse-
quent push to enroll and maintain an increasing number of
people living with HIV on treatment. These social and behav-
ioral interventions can play a crucial role in addressing the
signiﬁcant losses at each stage of the continuum of care,
which constitute a key barrier to achieving these goals.16–20
Health communication, broadly deﬁned as “the study
and use of communication strategies to inform and inﬂuence
[.] decisions that enhance health,”21 has played an important
role in the prevention response since the onset of the epi-
demic.22 Some of the key functions of health communication
include the provision of relevant health information, persuasion
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to help motivate behaviors that improve health outcomes, and
the facilitation and maintenance of social connections and
a supportive social environment for these desired health behav-
iors.23 Historically, communication methods can be divided
into 1 of 5 categories: intrapersonal, interpersonal, organiza-
tional, community, and public/mass communication.24
While earlier models viewed health communication as
a “one-time one-way communication ‘act’”25 primarily com-
prising messages targeting individual behavior change, recent
theoretical models consider health communication as a social
process that operates on multiple social ecological levels.23
Because communication is an integral part of interventions that
seek to address individual, community, and social, and political
factors,26 it can have a signiﬁcant impact at multiple levels of
implementation in each step of the continuum of care.23,27
Communication can be used to create health-seeking behavior,
on the demand side, and as a means to increase quality and
support, on the supply side, at the clinic and community levels.
In the context of HIV, communication can motivate people to
get tested and obtain their results, promote access to treatment,
link people living with HIV to medical and psychosocial care,
support continued retention in care, and help reduce stigma that
may prevent individuals from taking these actions.28
Although health communication has played an important
role in HIV prevention efforts, its potential to improve outcomes
across the continuum of care has not been fully realized, in part
because of the lack of a framework that translates health
communication theories and practices into speciﬁc interventions
to address each step in the treatment cascade. In this article, we
provide illustrative examples of the speciﬁc roles that health
communication can play in bolstering the continuum of care in
low- and middle-income countries, where limited resources
present considerable barriers to accessing HIV care and treat-
ment. In this process, we draw on recent reviews of the HIV
treatment literature and highlight studies that provide high-quality
evidence for interventions that incorporate health communication
components. The selected examples focus primarily on interper-
sonal communication, in individual and group settings, and
mobile communication technologies, reﬂecting the bulk of the
interventions discussed in the literature. Many of the high-quality
studies cited in the literature originate from sub-Saharan Africa,
reﬂecting researchers’ attention to the acute HIV epidemic in this
region, but we also include examples from other regions of the
world in an effort to broaden the scope of discussion and to
highlight the versatility of speciﬁc intervention strategies. While
we follow the World Health Organization’s approach in high-
lighting the similarities in the challenges across the treatment
continuum that result from resource limitations,15 successful in-
terventions clearly tailor these programs to the speciﬁc needs of
local populations. Finally, we make recommendations for future
research on health communication in support of the full contin-
uum of HIV, including treatment, care, and prevention.
FROM POSITIVE TEST RESULTS TO
TREATMENT INITIATION
A considerable challenge in improving outcomes of
HIV treatment is to ensure that those who have tested positive
can be, and are, linked to HIV care and treatment. While the
number of people older than 15 years who received an HIV
test in low- and middle-income country settings had risen to
more than 118 million in 2012, many do not receive their
results, undergo CD4 testing and clinical staging, enroll in
pre-ART care, or initiate ART.15 According to recent esti-
mates, in some settings only one-ﬁfth of those with a positive
diagnosis undergo CD4 count testing, and nearly one-quarter
of those eligible for ART may die before initiating it.29 This
loss is more pronounced among men than women.15,30
Key barriers to linkage to care in low- and middle-
income countries include lack of integration in health care
systems of the various service from testing to treatment,
coupled with signiﬁcant limitations in equipment, personnel,
and training, stock-outs of essential drugs, high transportation
and out-of-pocket costs for patients, as well as social barriers,
including stigma and lack of social support.15 People living
with HIV who are asymptomatic may not perceive a need for
care or maintain the motivation to continue clinical monitor-
ing in the face of these constraints.31
A number of promising interventions have been used to
address these structural, social, and personal barriers, some of
which have signiﬁcant health communication components.
Current research underlines the importance of interpersonal
communication in linkage to care through counseling, both in
clinical settings and at patients’ homes. For instance, a RCT
in Uganda found that enhanced posttest counseling coupled
with home visits and continued counseling support from
trained volunteers signiﬁcantly improves the uptake of pre-
ART care.32 Counselors in the intervention arm received addi-
tional training emphasizing disclosure of HIV status and the
importance of pre-ART care leading to enrollment in ART.
Subsequently, a community support worker reinforced these
messages during monthly home visits. Those who received
the enhanced counseling and home visits were almost twice
as likely as those in the standard counseling group to return
for pre-ART care within 5 months. Wanyenze et al33 tested
a similar intervention in Uganda, in which participants who
tested HIV positive in a hospital-based setting were random-
ized to receive standard posttest counseling on linkage to care
or to receive enhanced counseling that included facilitated
disclosure, introduction to HIV clinic staff, appointment
reminder phone calls, and home visits for appointment re-
minders if needed. Over follow-up of more than 1 year, they
found that the intervention improved HIV clinic attendance
by women, but not by men, and reduced the time to initiation
of ART for those eligible men, but not for women.
IMPROVING ART ADHERENCE
After an individual has initiated therapy, other formi-
dable barriers arise, as many struggle with taking prescribed
medications and must overcome the challenges of taking
medications with potentially serious side effects each day for
the rest of their lives, in the face of substantial barriers of
supply disruptions, out-of-pocket expenses related to visits
for medication reﬁlls, social stigma, and declining motivation
over time.34,35 Suboptimal adherence to ART compromises
optimal treatment outcomes.35 Recent estimates suggest that
there are wide variations in adherence, ranging from very
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poor adherence to nearly optimal.36 Speciﬁcally, clinics with
educational materials and food rations available were signif-
icantly associated with lower attrition compared with clinics
without these services. Furthermore, clinics with available
peer educators, support groups, and adherence reminder tools
were associated with lower rates of measured death compared
with clinics without these services.36
As in interventions focusing on linkage to care, health
communication has played an important and positive role in
adherence outcomes through interpersonal communication
and counseling. For example, Chung et al37 compared adher-
ence counseling provided by trained counselors to counseling
with the added use of an alarm, an alarm on its own, and the
absence of counseling or an alarm in Kenya. Those assigned
to the counseling interventions had signiﬁcantly higher levels
of adherence and lower rates of virological failure, whereas
the use of an alarm had no effect on these outcomes. In
a meta-analytic review of RCTs examining the relationship
between behavioral interventions and adherence, Simoni
et al38 concluded that behavioral interventions such as coun-
seling can improve adherence in diverse settings. For exam-
ple, a 4-session comprehensive intervention for couples,
delivered by a nurse practitioner, demonstrated some success
in increasing adherence.39 Group counseling and education
has also been demonstrated to improve adherence in a variety
of settings, including Brazil and India.40–42 An important fac-
tor affecting the impact of counseling on adherence is its
quality. Three cohort studies in sub-Saharan Africa that
trained counselors to improve their skills found higher levels
of adherence at the study’s end than at baseline.43–45
The caseload of many health care workers in low- and
middle-income countries is overwhelming; this signiﬁcantly
constrains the quality of counseling. Task shifting, decentral-
ization, and employment of lay health care workers have
emerged as promising interventions to address this problem in
low- and middle-income settings around the world, including
India, Malawi, South Africa and Uganda.15,41,46–48
Mobile communication technologies offer a promising
new approach to enhancing ART adherence. For instance,
a recent systematic review by Horvath et al49 found that 2
randomized trials in Kenya50,51 provided high-quality evidence
that mobile telephone short message service (SMS) consisting
of medication reminders, motivational messages, or questions
that required a response could improve adherence. The trial led
by Lester et al50, in which nurses or clinical ofﬁcers sent SMS
messages to inquire about participants’ well-being and called
unwell patients and nonresponders for additional support,
found that SMS support also improved rates of viral suppres-
sion. At the same time, in the Cameroon mobile phone SMS
study, standardized motivational text messages did not improve
adherence outcomes compared with usual care without text
messages,52 suggesting that additional research and the tailor-
ing of messaging to speciﬁc populations are necessary to
achieve consistently improved outcomes.
ENHANCING RETENTION IN ART CARE
Retaining patients in care once they have started ART
presents another signiﬁcant problem in the treatment cascade.
The World Health Organization reported that cohorts from 28
low- and middle-income countries retained on average 86%,
82%, and 72% of individuals in HIV care at 12, 24, and 60
months after treatment initiation.15 Factors associated with
attrition from care have included transport costs, distance to
clinic, shortage of health care workers, and patients’ low
levels of education.29 The “test and treat” paradigm poses
new challenges to retention in ongoing HIV care, as patients
initiate treatment at higher CD4 cell counts and therefore may
feel healthier and less motivated to continue care.
Health communication may play several roles in enhanc-
ing retention in care, ranging from improved overall provider-
patient communication in the context of patient-centered case
management to enhanced interpersonal communication, psy-
chosocial and organizational support from a community mem-
ber (“patient navigators” or guides) accompanying the patient to
health care visits and through counseling by community health
care workers.53,54 Communication interventions to help people
living with HIV stay in care synergize with efforts to improve
adherence, as both emphasize the importance of ART for long-
term survival and prevention of secondary transmission.
Successful retention in care has been demonstrated in
observational cohort studies of comprehensive community-based
programs that include interpersonal communication components.
For example, a community-based ART program in Rwanda
achieved 92.3% retention in care after 24 months from 2005 to
2008.55 This multifaceted combination community-based pro-
gram enrolled patients in education and support groups that
met the same day as clinic appointments and included daily
visits by trained community health workers who directly
observed therapy and offered psychosocial support. In an
additional analysis of the same program, Franke et al56 found
a higher retention rate with suppressed viral load (85% versus
79%) in one of the community-based accompaniment pro-
grams than in an ongoing clinic-based ART program, as well
as greatly reduced hazard of loss to follow-up (0.17) among
those with community-based accompaniment. Munoz et al57
found a greatly increased proportion retained in treatment
(90% versus 65% at 1 year following treatment initiation)
when comparing a pilot intervention of community-based
accompaniment with supervised antiretrovirals (CASA) with
a matched control group in Lima, Peru, and also observed
improved psychosocial outcomes in the intervention group.
In the CASA program, volunteers and ﬁeld supervisors
observed medication ingestion, provided social and emotional
support to patients and family members during home visits,
accompanied patients to health care visits, and reported patient
issues to health care providers. An ongoing trial that will con-
tribute evidence regarding the role of communication to
improve retention in care is WelTel Retain, a randomized clin-
ical trial that will assess the impact of weekly SMS messages
on retention at 1 year in Nairobi, Kenya.58
DISCUSSION
In today’s era of HIV prevention, there is a growing need
and demand to deliver effective behavioral interventions that
work to achieve results in concert with biomedical and struc-
tural interventions. As more people living with HIV become
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eligible to receive ART because of the new recommendations
of the World Health Organization to initiate therapy earlier,
these efforts will have a signiﬁcant impact on how many pa-
tients will link to care, initiate treatment, adhere to their treat-
ment regimen, and remain in treatment to achieve and sustain
viral suppression. Within this continuum of care, interventions
rely heavily on increasing the frequency and quality of inter-
personal communication in clinical settings as well as in homes
and communities. Individual and group counseling has played
a particularly important role in these efforts throughout the
continuum of care, from posttest counseling in HIV testing
and counseling services to adherence counseling provided by
lay health workers in the community. Interpersonal communi-
cation also plays an important role in integrated models of
treatment provision that rely on decentralization of care, patient
navigators or accompagnateurs, and community health work-
ers who offer support, education, and treatment supervision to
patients at all stages from testing through sustained treatment.
The employment of lay health workers and volunteers offers
a model for reducing the otherwise prohibitive personnel costs
of these interventions and engaging community members in
providing cost-effective and sustainable support for people liv-
ing with HIV. Mobile technologies present another cost-
effective means to enhance treatment outcomes at various
points of the continuum of care, and may be used as a bridge
to activate additional support for struggling patients, including
other kinds of interpersonal communication modalities, such as
telephone- or clinic-based support.59–61
This article considered studies that offered high-quality
evidence for interventions that included substantial health
communication components within the context of the treat-
ment cascade, which limited our discussion of the commu-
nication modalities to those represented within the pool of
available studies. Other health communication modalities that
address community and societal levels, including mass media,
school- or workplace-based education, or entertainment
modalities (eg, street theater) in addressing speciﬁc steps in
the treatment cascade, have been traditionally used in HIV
prevention efforts62–64 and may not yet be fully integrated into
interventions that link these communication strategies to treat-
ment outcomes. These modalities may provide additional pos-
sibilities for the incorporation of health communication into
interventions. For instance, there is preliminary evidence
from Malawi that provision of a workplace-based clinic and
support group can increase the uptake of HIV testing and
care, and provide good ART outcomes,65 but the communi-
cation aspects of this intervention were not clearly developed.
Although many behavioral intervention efforts clearly
incorporate health communication components, a framework
that explicitly draws on health communication theories and
practices is rarely identiﬁed as part of an intervention to
improve ART. Such a framework would need to map speciﬁc
communication theories, proximate determinants, and inter-
ventions to speciﬁc purposes at each step along the continuum
of care in both clinical and nonclinical settings, resulting in
a hands-on toolkit for program design. The development of
this framework would also facilitate clearer assessment of the
health communication components that might be applied
within comprehensive models of care.
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